Drug stocks diverge; Medicines Co. tanks
BOSTON (MarketWatch) -- Drug stocks diverged in early trading Wednesday, while shares of The Medicines Company tanked on news that it was discontinuing a key Phase III testing program for its new blood-thinner due to poor results.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here